Gland Surgery, an esteemed journal published by AME PUBLISHING COMPANY, is at the forefront of surgical research, particularly focusing on advancements in gland-related surgeries and their clinical implications. With an ISSN of 2227-684X and an E-ISSN of 2227-8575, this open-access journal provides a platform for disseminating high-quality research and insights into the intricate aspects of surgical practices, ranking in the Q2 category in Surgery as of 2023. As evidenced by its Scopus ranking at #153 out of 551 in the Medicine_Surgery field, Gland Surgery delivers valuable contributions to the global medical community, promoting the exchange of knowledge and innovative techniques. Operating from Hong Kong, China, and converging its excellence from 2016 to 2024, the journal is a critical resource for researchers, clinicians, and students keen on exploring the latest developments in the field. By fostering an open dialogue among professionals, Gland Surgery is accessible to a diverse audience seeking to enhance their understanding and practice in gland surgery.

Plastic and Reconstructive Surgery, an esteemed journal published by Lippincott Williams & Wilkins, serves as a cornerstone in the field of surgical research and innovation. This prestigious journal, ISSN 0032-1052 and E-ISSN 1529-4242, has been at the forefront of disseminating critical advancements in surgical practices since its inception in 1946, continuing to enhance the discipline through 2024. Recognized in the Q1 category of Surgery with an impressive Scopus rank of #86 out of 551 and in the 84th percentile, it offers a rich repository of peer-reviewed articles that cover the full spectrum of plastic and reconstructive surgery, including techniques, case studies, and innovative technologies. Although not an open-access journal, it remains integral for researchers, practitioners, and students alike, providing essential insights that drive the evolution of patient care and surgical methodologies. The journal's commitment to high-quality research and its reputable placing in academia makes it an indispensable resource for anyone involved in the surgical sciences.

Breast Cancer Management is a pivotal journal in the field of oncology and radiology, published by FUTURE MEDICINE LTD. Since its transition to Open Access in 2018, the journal has aimed to democratize access to cutting-edge research focused on innovative treatments and management strategies for breast cancer. With an ISSN of 1758-1923 and an E-ISSN of 1758-1931, it provides a platform for researchers and clinicians to share findings that enhance patient care and outcomes. The journal has garnered significant attention, placing in the Q3 quartile in Oncology and Q2 in Radiology, Nuclear Medicine, and Imaging as of 2023. Positioned in the United Kingdom, its editorial focus and rigorous peer-review process ensure that it remains at the forefront of breast cancer research. As breast cancer continues to be a major health concern globally, Breast Cancer Management serves as an essential resource for advancing knowledge and fostering collaboration among professionals in this vital area of medicine.

The International Journal of Breast Cancer is a premier academic platform dedicated to advancing the field of breast cancer research and treatment. Published by HINDAWI LTD, this journal embraces an Open Access model since 2011, ensuring that cutting-edge research is readily accessible to all, facilitating the dissemination of knowledge across the global scientific community. With its ISSN 2090-3170 and E-ISSN 2090-3189, the journal caters to a diverse audience comprising researchers, clinicians, and students engaged in oncology and pharmacology. The journal has consistently demonstrated its relevance, classified in the Q4 quartile for Cancer Research and the Q3 quartile for both Oncology and Pharmacology in the latest rankings. It currently ranks #151/272 in the Medicine & Pharmacology category and #232/404 in Medicine & Oncology according to Scopus, showcasing its adaptive role in an evolving field. Commencing in 2013 and continuing through to 2024, the journal is positioned to be an essential resource, addressing critical topics and fostering innovative solutions for breast cancer challenges.

CLINICS IN PLASTIC SURGERY is a premier journal dedicated to the field of plastic and reconstructive surgery, published by W B SAUNDERS CO-ELSEVIER INC. Renowned for its rigorous peer-review process and high-quality scholarly articles, this journal holds a prestigious Q1 quartile ranking in the Surgery category, as well as ranking #99 out of 551 in Scopus' Medicine & Surgery category, placing it in the 82nd percentile among its peers. Since its inception in 1974, the journal has provided a vital platform for the dissemination of cutting-edge research, clinical practices, and advancements in plastic surgery, catering to the interests of researchers, healthcare professionals, and students alike. Although it does not offer open access options, its content remains invaluable to those seeking to enhance their knowledge and stay informed about the latest developments in the field. With a commitment to excellence and an expansive scope, CLINICS IN PLASTIC SURGERY continues to play a crucial role in the education and advancement of surgical practitioners around the globe.

The Journal of Mammary Gland Biology and Neoplasia is an esteemed academic journal published by Springer/Plenum Publishers, focusing on cutting-edge research in the fields of cancer biology and oncology. With an ISSN of 1083-3021 and an E-ISSN of 1573-7039, this journal serves as a vital resource for researchers and practitioners aiming to deepen their understanding of mammary gland biology and its implications in neoplasia. The journal boasts a commendable impact factor, being categorized in the Q2 quartile for both Cancer Research and Oncology as of 2023, indicating its significant influence in these critical areas of study. Additionally, its ranking within Scopus reveals its competitiveness, with a rank of 154 out of 404 in Medicine - Oncology and 128 out of 230 in Biochemistry, Genetics and Molecular Biology - Cancer Research. Although the journal does not operate under an open access model, it continues to deliver vital insights and findings from 1996 to the present and is committed to advancing knowledge and fostering discussion around mammary gland health and cancer. Researchers, healthcare professionals, and students will find invaluable contributions within its pages, making it a cornerstone publication in the pursuit of cancer research and treatment.

Breast Care is a prominent academic journal published by KARGER, focusing on the dynamic fields of oncology and surgery. With an ISSN of 1661-3791 and an E-ISSN of 1661-3805, this peer-reviewed journal has established itself as an essential resource for researchers, clinicians, and students dedicated to advancing breast health. Based in Switzerland, it benefits from a strong academic reputation, evident in its impressive Scopus rankings—placing it in the 79th percentile in Surgery (Rank #115/551) and the 53rd percentile in Oncology (Rank #188/404). The journal is recognized for its rigorous exploration of current trends, innovations, and challenges in breast care, encompassing a wide scope from surgical techniques to oncological therapies. With a Q2 ranking in Oncology and a notable Q1 ranking in Surgery as of 2023, Breast Care not only contributes to the advancement of medical knowledge but also fosters interdisciplinary collaboration among healthcare professionals worldwide.

Radiologic Clinics of North America, published by W B Saunders Co-Elsevier Inc, stands as a pivotal resource in the field of medical imaging and radiology. With a solid history dating back to 1963 and converging years extending to 2024, this journal has established itself as a reputable platform for original research, comprehensive reviews, and insightful discussions that advance the knowledge and practice of radiology, nuclear medicine, and imaging. Holding a Q2 classification in both the miscellaneous medicine and radiology categories and positioned within the 56th percentile among its peers, its contributions are vital for both academic research and clinical applications. Although it does not offer open access, the journal remains accessible through institutional subscriptions and is a must-read for researchers, healthcare professionals, and students keen on the latest developments in radiological practices. With a dedicated editorial board and a commitment to the highest academic standards, Radiologic Clinics of North America continues to shape the future of the medical imaging field.

Journal of Breast Imaging is an esteemed peer-reviewed journal dedicated to advancing the field of breast imaging, published by Oxford University Press. Since its inception in 2019, the journal has been instrumental in disseminating innovative research and clinical practices, contributing vital knowledge to the domains of Radiology, Nuclear Medicine, and Ultrasound Technology. Notably, it holds a respectable impact factor and is categorized in the Q2 quartile for both applicable categories, asserting its position as a significant resource within the scholarly community. With a commendable ranking of #153/333 in Radiology, and #31/63 in Radiological and Ultrasound Technology, the journal consistently showcases groundbreaking studies that influence best practices and set a benchmark for practitioners and researchers alike. Although it currently does not offer open access, the journal prioritizes high-quality research that is pivotal for understanding and enhancing breast imaging methodologies at a global level. By exploring topics that range from the latest imaging techniques to innovative diagnostic technologies, the Journal of Breast Imaging serves as a cornerstone for professionals seeking to enhance their knowledge and expertise in this vital area of health care.

Breast Cancer-Targets and Therapy is a leading journal in the field of oncology, published by DOVE MEDICAL PRESS LTD in New Zealand. Established as an Open Access journal in 2009, it offers a platform for researchers and healthcare professionals to disseminate innovative findings and therapeutic strategies related to breast cancer. With an impressive ranking in the Q2 category of oncology journals as of 2023, and placed at Rank #203/404 in the Scopus database, this journal facilitates the exchange of high-quality research aimed at improving patient outcomes and advancing clinical practices. Covering a wide array of topics from basic research to clinical trials, Breast Cancer-Targets and Therapy plays a crucial role in bridging the gap between scientific discovery and practical application. Researchers, professionals, and students alike will find the journal a valuable resource for the latest advancements and best practices in breast cancer treatment.